ARTICLE | MDMA Cures Chronic, Treatment-Resistant PTSD

by Bill Kovski October 07, 2016 0 Comments

ARTICLE | MDMA Cures Chronic, Treatment-Resistant PTSD

Artist- Brad Holland

In this revolutionary study examining the efficacy of MDMA-assisted psychotherapy vs. PTSD, 20 patients with chronic, treatment-resistant PTSD were either given MDMA and psychotherapy or a placebo and psychotherapy.
The results are nothing short of a miracle: 83% of subjects given MDMA and psychotherapy were cured of their PTSD symptoms compared to 25% of subjects who received psychotherapy alone.
The study also found:
There were no drug-related serious adverse events, adverse neurocognitive effects or clinically significant blood pressure increases. MDMA-assisted psychotherapy can be administered to post traumatic stress disorder patients without evidence of harm, and it may be useful in patients refractory to other treatments.
Longterm use of the psychedelics LSD, psilocybin mushrooms, peyote, and mescaline does not cause mental health problems according to a new study.  The study shows the use of the psychedelics may even reduce the rate of mental health problems.
Lifetime use of psilocybin or mescaline, and use of LSD in the past year also decreased rates of major psychological distress and the use of psychiatric prescription medications.

21,967 respondents (13.4% weighted) reported lifetime psychedelic use. There were no significant associations between lifetime use of any psychedelics, lifetime use of specific psychedelics (LSD, psilocybin, mescaline, peyote), or past year use of LSD and increased rate of any of the mental health outcomes. Rather, in several cases psychedelic use was associated with lower rate of mental health problems. We did not find use of psychedelics to be an independent risk factor for mental health problems.

Original article found here:

Bill Kovski
Bill Kovski